2.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.69
Aprire:
$2.73
Volume 24 ore:
1.67M
Relative Volume:
0.43
Capitalizzazione di mercato:
$258.28M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-19.76
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-14.66%
1M Prestazione:
-34.17%
6M Prestazione:
-34.01%
1 anno Prestazione:
-39.21%
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GDRX
Goodrx Holdings Inc
|
2.62 | 913.07M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
270.50 | 44.75B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
65.69 | 12.29B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.73 | 8.92B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
46.42 | 9.04B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
34.79 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
How strong is GoodRx Holdings Inc. stock revenue growthRate Hike & Verified Chart Pattern Signals - newser.com
Can GoodRx Holdings Inc. stock double in next 5 yearsJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
How GoodRx Holdings Inc. stock performs after earningsM&A Rumor & Safe Entry Trade Reports - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AITrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzedWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Ranking GoodRx Holdings Inc. among high performing stocks via toolsTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price action2025 Retail Activity & Verified Entry Point Signals - newser.com
GoodRx (NASDAQ:GDRX) Sets New 1-Year LowWhat's Next? - MarketBeat
GoodRx Holdings, Inc.Class A Common Stock (NQ: GDRX - FinancialContent
GoodRx Holdings Inc. (GDRX) PT Lowered to $3 at BofA Securities - StreetInsider
GoodRx stock falls as BofA lowers price target on weight loss initiatives - Investing.com Nigeria
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
Officer Nabiey Acquires 3,085 Of GoodRx Holdings Inc [GDRX] - TradingView
Goodrx stock hits 52-week low at 2.94 USD By Investing.com - Investing.com Nigeria
Novo Nordisk Leans Into Affordability Amid Rising Competition - Benzinga
GoodRx (GDRX) Expands Access to GLP-1 Medications with New Initiatives - GuruFocus
Goodrx stock hits 52-week low at 2.94 USD - Investing.com
GoodRx stock ticks up after launching weight loss subscription service - Investing.com India
GoodRx stock ticks up after launching weight loss subscription service By Investing.com - Investing.com Australia
GoodRx (Nasdaq: GDRX) unveils $199 Ozempic, Wegovy and $39 GLP-1 plan subscription - Stock Titan
Using Ichimoku Cloud for GoodRx Holdings Inc. technicalsSell Signal & High Win Rate Trade Tips - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesRate Hike & Weekly Setup with ROI Potential - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com
GoodRx (NASDAQ:GDRX) Downgraded by Wall Street Zen to Hold - MarketBeat
Custom watchlist performance reports with GoodRx Holdings Inc.Global Markets & Expert Approved Trade Ideas - newser.com
Does GoodRx Holdings Inc. fit your quant trading modelWeekly Gains Report & Accurate Intraday Trade Tips - newser.com
How currency fluctuations impact GoodRx Holdings Inc. stockChart Signals & Risk Managed Investment Signals - newser.com
GoodRx Holdings, Inc. $GDRX Shares Purchased by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
GoodRx Holdings, Inc. (GDRX) Stock Price Quote Today & Current Price Chart - Capital.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):